Reuters logo
BRIEF-Valbiotis confirms efficacy of Lipidrive in three models and finalizes recruitment for phase I/II
October 16, 2017 / 5:51 AM / 2 months ago

BRIEF-Valbiotis confirms efficacy of Lipidrive in three models and finalizes recruitment for phase I/II

Oct 16 (Reuters) - VALBIOTIS SAS:

* ‍LIPIDRIVE: EFFICACY CONFIRMED IN THREE MODELS, FINALIZATION OF RECRUITMENT FOR PHASE I/II IN HUMANS​

* ‍IN PROCESS OF RECRUITING 20 OBESE MALE VOLUNTEERS FOR STUDY, 18 OF WHICH HAVE ALREADY BEEN INCLUDED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below